Telephone-administered cognitive behaviour therapy (CBT) for the treatment of obsessive compulsive disorder: A randomized controlled trial

ISRCTN ISRCTN16800815
DOI https://doi.org/10.1186/ISRCTN16800815
Secondary identifying numbers RDO/28/1/26
Submission date
25/08/2005
Registration date
13/09/2005
Last edited
08/11/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Karina Lovell
Scientific

School of Nursing
Midwifery & Social Work
The University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific titleTelephone-administered cognitive behaviour therapy (CBT) for the treatment of obsessive compulsive disorder: A randomized controlled trial
Study objectivesExposure therapy and response prevention will yield equivalent clinical outcomes whether delivered by telephone or by face to face therapist contact in the treatment of obsessive-compulsive disorder
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedObsessive-compulsive disorder (OCD)
InterventionExposure therapy and response prevention delivered by either telephone or face to face
Intervention typeBehavioural
Primary outcome measureCBT delivered by telephone shows equivalent clinical outcome as face to face therapy and similar levels of satisfaction were reported.
Secondary outcome measuresCost-minimisation analysis shows that treatment by telephone is cheaper than face to face CBT. The main cost-driver is treatment time defined by the protocol and, for telephone-administered CBT, this duration was shorter.
Overall study start date01/10/2000
Completion date30/09/2002

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit16 Years
Upper age limit65 Years
SexBoth
Target number of participants80
Total final enrolment72
Key inclusion criteria1. Obsessive-compulsive disorder as the main presenting problem
2. Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for OCD
3. Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score of 16 and over
4. Aged between 16-65
5. Agree to, and give written consent to participate in the study
Key exclusion criteria1. Obsessions without overt compulsions
2. Obsessional slowness
3. Organic brain disease
4. On a stable dose of antidepressants or anxiolytic medication for less than 3 months
5. Past or present psychosis
6. Meet DSM-IV criteria for substance abuse or dependence
7. Currently on more than 10 mg of Diazepam or equivalent daily
8. Severe depression >30 on Beck Depression Inventory (BDI)
9. Suicidal intent
Date of first enrolment01/10/2000
Date of final enrolment30/09/2002

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

School of Nursing
Manchester
M13 9PL
United Kingdom

Sponsor information

North West Research and Development Support Unit (UK)
Government

c/o Ms Sue Riley
Institute for Public Health Research & Policy
The University of Salford
4th Floor Humphrey Booth House
Hulme Place
The Crescent
Salford
Manchester
M5 4AO
United Kingdom

Funders

Funder type

Government

North West Research and Development Support Unit, Salford (Ref: RDO/28/1/26) - regional NHS R&D funding stream

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 28/10/2006 Yes No

Editorial Notes

08/11/2022: Internal review.